Connect your AI

Innoviva, Inc. INVA Gross Profit

Gross Profit at other companies

PfizerPFE

$10.9B+0.3%

Merck & Co.MRK

$12.09B-0.2%

AbbVieABBV

$10.78B+15.4%

OrganonOGN

$783M-6.9%

Ionis PharmaceuticalsIONS

——

AlkermesALKS

——

Other financials

Income statement

Revenue$98.0M+10.6%

Operating income$38.2M-7.9%

Net income$186.6M+501%

EPS (diluted)$2.22+400%

Balance sheet

Cash & equivalents$603.1M+89.0%

Total debt$269.4M-40.3%

Total equity$1.3B—

Total assets$1.8B+46.4%

Cash flow

Operating cash flow$35.3M-27.4%

CapEx$492.0K—

Free cash flow$34.8M-28.4%

Valuation

Market cap$1.74B+51.8%

Enterprise value$1.4B+9.7%

P/E3.5×—

P/S4.1×+1.0×

Profitability

Gross margin73.7%-9.9pp

Operating margin38.1%-11.2pp

Net margin119.9%+107pp

FCF margin54.1%+5.3pp

Returns & leverage

Return on equity29.1%—

Debt / equity0.2×—

Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GrossProfit.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Innoviva, Inc.'s gross profit?: Innoviva, Inc. (INVA) reported gross profit of $75.83M in Q1 2026.
How has Innoviva, Inc.'s gross profit changed year-over-year?: Innoviva, Inc.'s gross profit increased by 3.4% year-over-year, from $73.32M to $75.83M.
What is the long-term trend for Innoviva, Inc.'s gross profit?: Over 2 years (2023 to 2025), Innoviva, Inc.'s gross profit has grown at a 11.8% compound annual growth rate (CAGR), from $246.04M to $307.67M.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.